Eric Blanchardon

TL;DR: It is now concluded that radon and its progeny should be treated in the same way as other radionuclides within the ICRP system of protection; that is, doses from rad on and its offspring should be calculated using I CRP biokinetic and dosimetric models.

TL;DR: The 2007 Recommendations of the International Commission on Radiological Protection introduced changes that affect the calculation of effective dose, and implied a revision of the dose coefficients for internal exposure, published previously in the Publication 30 series and Publication 68.

TL;DR: This review summarises the multidisciplinary work undertaken in the framework of the European project DoReMi (Low Dose Research towards Multidisciplinary Integration) to identify the most appropriate biomarkers for use in population studies and proposes a temporal classification of biomarkers that may be relevant for molecular epidemiology studies which need to take into account the time elapsed since exposure.

TL;DR: A roadmap is provided for biomarker development from discovery to implementation and used to summarise the current status of proposed biomarkers for epidemiological studies, with one biomarker identified in the final stages of development and as a priority for further research is radiation specific mRNA transcript profiles.

TL;DR: New experimental data on retention of uranium after chronic intake are presented, which are compared to values calculated from a biokinetic model that is based on experiments of acute exposure of rats to uranium, and comparison with model prediction showed that the accumulation of uranium in target organs after chronic exposure is overestimated.